UBS Group »

Adagio Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $57k 15k 3.94
2023-09-30 $2.0k 1.1k 1.70
2023-06-30 $1.7k 1.6k 1.06
2023-03-31 $22k 19k 1.20
2022-12-31 $24k 16k 1.50
2022-09-30 $3.0k 959 3.13
2022-06-30 $4.0k 1.1k 3.66
2022-03-31 $53k 12k 4.46
2021-12-31 $765k 96k 8.00